期刊文献+

帕珠沙星与左氧氟沙星治疗尿路感染的疗效比较 被引量:3

Comparison of Clinical Efficacy between Pazufloxacin and Levofloxacin in the Treatment of Urinary Infection
下载PDF
导出
摘要 目的比较帕珠沙星与左氧氟沙星治疗尿路感染的疗效.方法尿路感染患者60例随机分成帕珠沙星组与左氧氟沙星组各30例,分别给予帕珠沙星300 mg,左氧氟沙星200 mg,均为静脉滴注,bid,疗程5~14 d.结果帕珠沙星组与左氧氟沙星组的有效率分别为96.4%和92.6%,痊愈率分别为85.7%和70.3%,均差异无显著性 (P>0.05).结论帕珠沙星与左氧氟沙星治疗尿路感染的临床疗效相当. Objective To compare the clinical efficacy between pazufloxacin and levofloxacin in the treatment of urinary infection. Methods Sixty patients with urinary tract infection were randomised into two groups evenly (n = 30), the pazufloxacin group and the levofloxacin group. The pazufloxacin group were given pazufloxacin 0.3 g iv, bid, and the levofloxacin group levofloxacin 0.2 g iv, bid. The treatment period was 5-14 d. Results The effective rate in pazufloxacin group was 96.4% , and in levofloxacin group 92.6%. The cured rates in pazufloxacin group was 85.7% and in levofloxacin group 70.4%. There was no significant difference between the two groups ( P〉0.05 ). Conclusion Pazufloxacin has the same efficacy as levofloxacin in the treatment of urinary tract infection.
出处 《医药导报》 CAS 2005年第9期767-768,共2页 Herald of Medicine
关键词 帕珠沙星 左氧氟沙星 尿路感染 Pazufloxacin Levofloxacin Urinary tract infection
  • 相关文献

参考文献7

  • 1Mitsuyama J,Miyazaki S,Ishii Y,et al . Antibacterial acti-vity of a new injectiable quinolone pazufloxacin mesilate in vitro and in vivo[J]. Japan J Chemother,1999,47(Suppl 1):1.
  • 2Mikamo H,Sato Y,Hayasaki Y,et al . In vitro activities of pazufloxacin,an injectable new quinolone,against bacteria causing infections in obstertric and gynecological patients [J]. Japan J Chemother,1999,47(Suppl 1):16.
  • 3Nishino T,Ikeda Y,Otsuki M,et al . In vitro and in vivo antibacterial activity of pazufloxacin mesilate,a new parenteral fluoroquinolone [J]. Japan J Chemother,1999,47(Suppl 1):25.
  • 4Nakata M,Yamashiro Y,Shimakura M,et al. Pharmacokine-tics of pazufloxacin mesilate in expeimental animal [J].Japan J Chemother,1999,47(Suppl 1):65.
  • 5Takei M,Fukuda H,Kishii R,et al .Target preference of 15 quinolone against staphylococcus aureus,based on antibacterial activities and target inhibition [J]. Antimicrob Agents Chemother,2001,45(12):3544-3547.
  • 6Hayakawa H,Takano Y,Sogame Y,et al . Disposition of 14C-pazufloxacin mesilate in rats and mice [J]. Japan J Chemother,1999,47(Suppl 1):88.
  • 7杨信怡,游雪甫.注射用帕珠沙星的药理研究和临床应用[J].国外医药(抗生素分册),2003,24(2):80-87. 被引量:59

二级参考文献1

  • 1Nakashima M Uemura K Kosuge K et al.Phase Ⅰ clinical study of pazufloxacin mesilate [J].Japan J Chemother,1999,47(1):141-141.

共引文献58

同被引文献49

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部